Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-08

Clinical Trial Update: Precise and Objective Identification of Bertolotti Syndrome Using Novel Kinematic Biomarkers

View source ↗

Summary

The Cleveland Clinic-led clinical trial evaluates using novel kinematic biomarkers to precisely identify Bertolotti's syndrome, potentially improving diagnostic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Cleveland Clinic | Conditions: Bertolotti's Syndrome, Lower Back Pain | Status: ACTIVE_NOT_RECRUITING